Mettler-Toledo International (NYSE:MTD) Announces Earnings Results, Beats Estimates By $0.60 EPS

Mettler-Toledo International (NYSE:MTDGet Free Report) announced its earnings results on Thursday. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60, Zacks reports. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%. Mettler-Toledo International updated its Q1 2026 guidance to 8.600-8.750 EPS and its FY 2026 guidance to 46.050-46.700 EPS.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock traded down $6.41 during trading on Thursday, hitting $1,383.32. 174,284 shares of the stock were exchanged, compared to its average volume of 134,790. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,525.17. The stock’s fifty day moving average is $1,426.00 and its 200 day moving average is $1,357.10. The stock has a market cap of $28.26 billion, a PE ratio of 34.50, a P/E/G ratio of 4.07 and a beta of 1.42.

Insider Activity

In other Mettler-Toledo International news, Director Elisha W. Finney sold 474 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the sale, the director owned 311 shares in the company, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gerry Keller sold 236 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the transaction, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. This represents a 59.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 19,565 shares of company stock worth $28,683,737 over the last three months. Insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP bought a new stake in Mettler-Toledo International in the third quarter worth about $49,000. State of Wyoming acquired a new position in Mettler-Toledo International in the second quarter worth approximately $58,000. Kelleher Financial Advisors bought a new position in shares of Mettler-Toledo International in the third quarter valued at $61,000. MUFG Securities EMEA plc acquired a new stake in shares of Mettler-Toledo International during the 2nd quarter valued at $72,000. Finally, Geneos Wealth Management Inc. lifted its position in shares of Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 30 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Barclays decreased their target price on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Morgan Stanley assumed coverage on Mettler-Toledo International in a research report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price target on the stock. Finally, Stifel Nicolaus boosted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,441.67.

Check Out Our Latest Research Report on MTD

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Read More

Earnings History for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.